CDMO + Emerging Bio Partnership with Forge's John Maslowski and Ray's Jenny Holt

We love to hear from our listeners. Send us a message. What constitutes a healthy, productive, and successful relationship between an emerging biopharma company and its contract develpment and manufacturing outsourcer (CDMO)? Jenny Holt, Chief Development Officer at the biopharma company Ray Therapeutics has some opinions. So does John Maslowski, Chief Commercial Officer at the CDMO Forge Biologics. Think they align?On this episode of the Business of Biotech, we dig into the trust, tech...